Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEO101 for stable nasal carriage of Staphylococcus aureus in adults
ACTRN12607000267459Phase 2Completed
- Sponsor
- Neosil
- Start
- Jun 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Staphylococcus aureus nasal carriage comparing NEO101 with Vehicle placebo (2 arms). Primary endpoint: Safety and local tolerability of intranasal NEO101. Started Jun 2007; status: completed.
02
Drugs
NEO101
03
Conditions
Staphylococcus aureus nasal carriage
Beyond the preview
Go deeper on ACTRN12607000267459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000267459.